Sareyaan Pharma Private Limited
About Sareyaan Pharma Private Limited
Data last updated:
Sareyaan Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 13 March 2023.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U21001PN2023PTC218590.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Madhuri Hemant Shinde and Hemant Hanmant Shinde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 36 Hake Wasti Nr Omkar Park, Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹86.65 Lakh. For the same year it recorded a net profit of ₹98,724 (net margin 1.1%) and EBITDA of ₹98,724 (EBITDA margin 1.1%).
Company details
Contact details
Sareyaan Pharma Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressSno.36 Hake Wasti Nr Omkar Park, Manjari Farm Manjari Bk, Pune, Maharashtra, India – 412307
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sareyaan Pharma Private Limited
FY 2025 filings availableSareyaan Pharma Private Limited reported revenue of ₹86.65 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹98,724 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹98,724 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.1% | ||
| Net Profit Margin | 1.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sareyaan Pharma Private Limited, buy the company report.
Board of directors of Sareyaan Pharma Private Limited
Sareyaan Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhuri Hemant Shinde | Director | 13 Mar 2023 | 3 Years 7 Months | Current |
| Hemant Hanmant Shinde Also directs: Jagrutii Rehab Centre Private Limited | Additional Director | 24 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Sareyaan Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vqure Pharmaceuticals Private Limited | ₹86.82 Lakh (FY 2023) | -36.0% | Thane, Maharashtra, India | |||
| Elemensis Lifesciences Private Limited | ₹86.75 Lakh (FY 2025) | 373.0% | Delhi, India | |||
| Prescription Medicines Pvt Ltd | ₹86.68 Lakh (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Tenfold Pharmaceuticals Private Limited | ₹86.68 Lakh (FY 2025) | -19.0% | Jaipur, Rajasthan, India | |||
| Xeno Life Science Private Limited | ₹86.67 Lakh (FY 2024) | 17.0% | Kovur, Tamil Nadu, India | |||
| Sareyaan Pharma Private Limitedthis company | ₹86.65 Lakh (FY 2025) | ₹98,724 | 1.1% | Pune, Maharashtra, India | ||
| Teja Cargo & Logistics (India) Private Limited | ₹86.65 Lakh (FY 2025) | -50.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Walnut Healthcare Private Limited | ₹86.44 Lakh (FY 2023) | 974.0% | New Delhi, Delhi, India | |||
| Delegates Northernlight Private Limited | ₹86.41 Lakh (FY 2025) | -30.0% | Hassan, Karnataka, India | |||
| Capsyp Medica Private Limited | ₹86.35 Lakh (FY 2024) | -18.0% | Kolkata, West Bengal, India | |||
| Strotay Life Sciences Private Limited | ₹86.1 Lakh (FY 2024) | -10.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Sareyaan Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sareyaan Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sareyaan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sareyaan Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sareyaan Pharma Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Hemant Hanmant Shinde was appointed as Additional Director on 24 Nov 2025.
Frequently asked questions
Sareyaan Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 13 March 2023 (3+ years old) and is registered under CIN U21001PN2023PTC218590.
Sareyaan Pharma has 2 current directors:
- Madhuri Hemant Shinde - Director
- Hemant Hanmant Shinde - Additional Director
The latest financial statements of Sareyaan Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Sareyaan Pharma is U21001PN2023PTC218590. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sareyaan Pharma was incorporated on 13 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Sareyaan Pharma by revenue are Vqure Pharmaceuticals Private Limited, Elemensis Lifesciences Private Limited, Prescription Medicines Pvt Ltd, Tenfold Pharmaceuticals Private Limited, Xeno Life Science Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Hemant Hanmant Shinde was appointed as Additional Director on 24 Nov 2025. Kiran Dadasaheb Sabale ceased to be Director on 24 Nov 2025. Kiran Dadasaheb Sabale was appointed as Director on 13 Mar 2023. Sareyaan Pharma has 4 board changes on record in total.
The registered office of Sareyaan Pharma is at Sno.36 Hake Wasti Nr Omkar Park, Manjari Farm Manjari Bk, Pune, Maharashtra, India – 412307.
Sareyaan Pharma operates in the paper industry, in the paper and paper products segment.
Sareyaan Pharma can be reached at its registered office: Sno.36 Hake Wasti Nr Omkar Park, Manjari Farm Manjari Bk, Pune, Maharashtra, India – 412307.
Sareyaan Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
